- Home
- AEHR
AEHR
Aehr Test Systems
as of 03-06-2026 3:42pm EST
$35.58
$4.63
-11.51%
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
| Founded: | 1977 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 858.8M | IPO Year: | 1997 |
| Target Price: | $21.00 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.18 | EPS Growth: | -111.61 |
| 52 Week Low/High: | $6.27 - $46.95 | Next Earning Date: | 04-08-2026 |
| Revenue: | $58,968,000 | Revenue Growth: | -10.95% |
| Revenue Growth (this year): | -17.58% | Revenue Growth (next year): | 60.20% |
| P/E Ratio: | -224.39 | Index: | N/A |
| Free Cash Flow: | -12392000.0 | FCF Growth: | N/A |
AI-Powered AEHR Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 68.52%
68.52%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Aehr Test Systems (AEHR)
POSEDEL RHEA J
Sell
Director
AEHR Feb 13, 2026
Avg Cost/Share
$30.02
Shares
13,998
Total Value
$420,151.37
Owned After
456,979
SEC Form 4
SPORCK ALISTAIR N
Sell
VP Contactor Business Unit
AEHR Feb 9, 2026
Avg Cost/Share
$27.58
Shares
3,000
Total Value
$82,716.00
Owned After
25,453
OLIPHANT LAURA
Sell
Director
AEHR Jan 22, 2026
Avg Cost/Share
$31.44
Shares
4,546
Total Value
$142,750.34
Owned After
18,572
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| POSEDEL RHEA J | AEHR | Director | Feb 13, 2026 | Sell | $30.02 | 13,998 | $420,151.37 | 456,979 | |
| SPORCK ALISTAIR N | AEHR | VP Contactor Business Unit | Feb 9, 2026 | Sell | $27.58 | 3,000 | $82,716.00 | 25,453 | |
| OLIPHANT LAURA | AEHR | Director | Jan 22, 2026 | Sell | $31.44 | 4,546 | $142,750.34 | 18,572 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 8, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 8, 2026 · 100% conf.
AI Prediction BUY
1D
+14.71%
$26.04
5D
+15.65%
$26.25
20D
+8.96%
$24.73
Price: $22.70 Prob +5D: 100% AUC: 1.000
0001654954-26-000197
aehr_8k.htm0001040470false00010404702026-01-082026-01-08iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 8, 2026
AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
California
000-22893
94-2424084
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
400 KATO TERRACE
FREMONT, CA 94539
(Address of principal executive offices, including zip code)
510-623-9400
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share
AEHR
The NASDAQ Capital Market
Item 2.02. Results of Operations and Financial Condition.
On January 8, 2026, Aehr Test Systems, a California corporation (the “Company”), issued a press release announcing the Company’s financial results for its second quarter ended November 28, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information in this Item 2.02 and Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release dated January 8, 2026, announcing the Company's fiscal 2026 second quarter financial results and reinstatement of fiscal 2026 guidance
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AEHR TEST SYSTEMS
Date: January 8, 2026 By:/s/ Chris P. Siu
Chris P. Siu Executive Vice President of Finance and Chief Financial Officer
3
2025 Q3 Q3 2025 Earnings
8-K Oct 6, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 6, 2025
0001654954-25-011494
aehr_8k.htm0001040470falsefalse00010404702025-10-062025-10-06iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 6, 2025
AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
California
000-22893
94-2424084
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
400 KATO TERRACE
FREMONT, CA 94539
(Address of principal executive offices, including zip code)
510-623-9400 (Registrant’s telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share
AEHR
The NASDAQ Capital Market
Item 2.02. Results of Operations and Financial Condition.
On October 6, 2025, Aehr Test Systems, a California corporation (the “Company”), issued a press release announcing the Company’s financial results for its first quarter ended August 29, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information in this Item 2.02 and Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of Aehr Test Systems dated October 6, 2025 entitled “Aehr Test Systems Reports Fiscal 2026 First Quarter Financial Results”
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AEHR TEST SYSTEMS
Date: October 6, 2025By:/s/ Chris P. Siu
Chris P. Siu Executive Vice President of Finance and Chief Financial Officer
3
2025 Q2 Q2 2025 Earnings
8-K Jul 8, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 8, 2025
0001654954-25-007859
aehr_8k.htm0001040470false00010404702025-07-082025-07-08iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 8, 2025
AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
California 000-22893 94-2424084
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
400 KATO TERRACE
FREMONT, CA 94539
(Address of principal executive offices, including zip code)
510-623-9400
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Name of each exchange on which registered
Symbol(s)
Common Stock, par value $0.01 per share
AEHR
The NASDAQ Capital Market
Item 2.02. Results of Operations and Financial Condition.
On July 8, 2025, Aehr Test Systems, a California corporation (the “Company”), issued a press release announcing the Company’s financial results for its fourth quarter and fiscal year ended May 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information in this Item 2.02 and Exhibit 99.1 are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of Aehr Test Systems dated July 8, 2025 entitled “Aehr Test Systems Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results”
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AEHR TEST SYSTEMS
Date: July 8, 2025 By:s/ Chris P. Siu
Chris P. Siu Executive Vice President of Finance and Chief Financial Officer
3
Latest Aehr Test Systems News
AEHR Breaking Stock News: Dive into AEHR Ticker-Specific Updates for Smart Investing
Simply Wall St.
Aehr Test Systems (AEHR) Is Up 11.1% After Securing Major AI Data Center Burn-In Order – Has The Bull Case Changed?
📊
AI Sentiment
Positive
6/10
Compare AEHR vs Leading Stocks
See how AEHR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AEHR Aehr Test Systems - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.